Literature DB >> 21658614

The microenvironment in follicular lymphoma.

Daphne de Jong1, Thierry Fest.   

Abstract

It has become increasingly clear that proliferation and survival in FL is not only driven by genetic changes, but also and possibly even predominantly by the close interaction with the immune microenvironment and stromal cells. Based on in vitro studies and experimental models and supported by immunohistochemical studies in biopsy specimens of FL patients, classes of CD4+ T-cell populations including follicular helper T cells and regulatory T cells are now identified as major players to regulate the delicate balance of effector populations into a supportive microenvironment. These insights may thoroughly change the therapeutic approaches in FL and translate into programs that combine direct cytotoxic and indirect immunomodulatory aspects.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21658614     DOI: 10.1016/j.beha.2011.02.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  22 in total

1.  Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathways.

Authors:  Daniel J Medina; Lauri Goodell; John Glod; Céline Gélinas; Arnold B Rabson; Roger K Strair
Journal:  Haematologica       Date:  2012-02-27       Impact factor: 9.941

2.  Assessing the prognostic impact of immune cell infiltrates in follicular lymphoma.

Authors:  Falko Fend; Leticia Quintanilla-Martínez
Journal:  Haematologica       Date:  2014-04       Impact factor: 9.941

Review 3.  Role of the tumor microenvironment in mature B-cell lymphoid malignancies.

Authors:  Nathan H Fowler; Chan Yoon Cheah; Randy D Gascoyne; John Gribben; Sattva S Neelapu; Paolo Ghia; Catherine Bollard; Stephen Ansell; Michael Curran; Wyndham H Wilson; Susan O'Brien; Cliona Grant; Richard Little; Thorsten Zenz; Loretta J Nastoupil; Kieron Dunleavy
Journal:  Haematologica       Date:  2016-05       Impact factor: 9.941

4.  Low absolute CD4+ T cell counts in peripheral blood are associated with inferior survival in follicular lymphoma.

Authors:  Lu He; Jin-Hua Liang; Jia-Zhu Wu; Yue Li; Shu-Chao Qin; Yi Miao; Yu-Jie Wu; Yan Wang; Li Wang; Lei Fan; Jian-Yong Li; Wei Xu
Journal:  Tumour Biol       Date:  2016-07-07

5.  Oncogenic Rag GTPase signaling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR.

Authors:  Ana Ortega-Molina; Nerea Deleyto-Seldas; Joaquim Carreras; Alba Sanz; Cristina Lebrero-Fernández; Camino Menéndez; Andrew Vandenberg; Beatriz Fernández-Ruiz; Leyre Marín-Arraiza; Celia de la Calle Arregui; Ana Belén Plata-Gómez; Eduardo Caleiras; Alba de Martino; Nuria Martínez-Martín; Kevin Troulé; Elena Piñeiro-Yáñez; Naoya Nakamura; Shamzah Araf; Gabriel D Victora; Jessica Okosun; Jude Fitzgibbon; Alejo Efeyan
Journal:  Nat Metab       Date:  2019-08-19

Review 6.  The emerging role of immune checkpoint inhibition in malignant lymphoma.

Authors:  Ida Hude; Stephanie Sasse; Andreas Engert; Paul J Bröckelmann
Journal:  Haematologica       Date:  2016-11-24       Impact factor: 9.941

Review 7.  Management of indolent lymphoma: where are we now and where are we going.

Authors:  Matthew A Lunning; Julie M Vose
Journal:  Blood Rev       Date:  2012-10-09       Impact factor: 8.250

8.  Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity.

Authors:  Ricardo García-Muñoz; Ascensión López-Díaz-de-Cerio; Jesus Feliu; Angel Panizo; Pilar Giraldo; Mercedes Rodríguez-Calvillo; Carlos Grande; Esther Pena; Mayte Olave; Carlos Panizo; Susana Inogés
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

Review 9.  Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine.

Authors:  Ruifang Sun; L Jeffrey Medeiros; Ken H Young
Journal:  Mod Pathol       Date:  2016-08-01       Impact factor: 7.842

10.  The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium.

Authors:  Birgitta Sander; Daphne de Jong; Andreas Rosenwald; Wanling Xie; Olga Balagué; Maria Calaminici; Joaquim Carreras; Philippe Gaulard; John Gribben; Anton Hagenbeek; Marie José Kersten; Thierry Jo Molina; Abigail Lee; Santiago Montes-Moreno; German Ott; John Raemaekers; Gilles Salles; Laurie Sehn; Christoph Thorns; Björn E Wahlin; Randy D Gascoyne; Edie Weller
Journal:  Haematologica       Date:  2014-02-07       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.